Webinar: “A global update on the use of delamanid for programmatic management of drug-resistant tuberculosis”

In the “Implementation Innovations” webinar series from USAID and SIAPS,  Dr. Jennifer Furin and Dr. Gunta Dravniece presented on October 13, 2015 about new TB drug delamanid. This webinar provided up-to-date information on the use of delamanid for treatment of patients under program conditions. This webinar may be of special interest to consultants, program managers, and clinicians working in the field of drug-resistant TB.

To access the recording of this webinar, please click on the following link:  https://ac.usaid.gov/p24203660/

The link to the slides from this and other webinars in the series are available here:  https://www.dropbox.com/sh/ccw4jeyut7262uo/AADGJ4dbCLeKBa4fvsV82Zkoa?dl=0

For more information, questions, or to suggest other webinar topics, please contact Jennifer Furin atjenniferfurin@gmail.com

To subscribe to the Weekly Newsletter of new posts, enter your email here:


By Jennifer Furin, Gunta Dravniece

Published: Oct. 27, 2015, 11:23 p.m.

Last updated: Oct. 28, 2015, 11:09 a.m.

Print Share